Stock ALRN AILERON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Aileron Therapeutics, Inc.

Equities

ALRN

US00887A2042

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-02 pm EDT 		5-day change 1st Jan Change
2.76 USD -1.43% Intraday chart for Aileron Therapeutics, Inc. -8.00% -9.47%
Jun. 18 Certain Warrants of Aileron Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 18-JUN-2024. CI
Jun. 18 Certain Common Stock of Aileron Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 18-JUN-2024. CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aileron Therapeutics, Inc. Announces Executive Changes
CI
Aileron Therapeutics, Inc. Announces Board Changes
CI
Aileron Therapeutics Names Brian Windsor as CEO
MT
Aileron Therapeutics, Inc. Announces Appointment of Brian Windsor as President and to the Board of Directors
CI
Aileron Therapeutics, Inc. Announces CEO Changes
CI
Aileron Therapeutics, Inc. Announces Resignation of Nolan Sigal, M.D., Ph.D. from Board of Directors, Member of Nominating and Corporate Governance Committee
CI
Aileron Therapeutics Chief Medical Officer Leaves
MT
Aileron Therapeutics, Inc. Appoints Manuel Aivado as Principal Financial Officer and Principal Accounting Officer
CI
Oncorus Names Richard Wanstall CFO
MT
Aileron Therapeutics, Inc. Announces Resignation of Richard J. Wanstall as Chief Financial Officer, Effective from May 6, 2022
CI
Insider Trends: Aileron Therapeutics Sees 90 Days of Insider Selling, Trend Reduced with Share Buy
MT
Aileron Therapeutics Announces the Promotion of Richard J. Wanstall to Chief Financial Officer and Treasurer
CI
Aileron Therapeutics Announces Board Appointments
CI
Aileron Therapeutics, Inc. Announces Board Changes
CI
Aileron Therapeutics, Inc. Announces Board Changes
CI
Aileron Therapeutics Appoints Kathryn Gregory as Chief Business Officer
CI
Aileron Therapeutics, Inc. Announces Resignation of Scott Kapnick from the Board of Directors
CI
Aileron Therapeutics Announces Management Changes
CI
Aileron Therapeutics Announces Management Changes
CI
Aileron Therapeutics, Inc. Announces Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALRN Stock
  4. News Aileron Therapeutics, Inc.
  5. Insiders